Market Overview:
INAAT aids in rapid and accurate detection of nucleic acid sequences with real-time monitoring using portable devices without the need for sophisticated thermal cycling equipment. The technology provides efficient point-of-care testing for various infectious diseases and has applications in fields like healthcare, biodefence and veterinary diagnostics.
Market key trends:
The global INAAT market is witnessing significant growth owing to wide adoption of rapid point-of-care molecular diagnostics. Mobile (point-of-care) testing segment is gaining prominence with ease of use and accessibility of nucleic acid-based diagnostics at the patient side, clinics, hospitals and community healthcare centres. Growing incidences of infectious diseases like influenza, sepsis and other respiratory illnesses are driving lucrative opportunities. Moreover, increasing R&D funding and investments from government and private players for development of portable, battery-operated and wireless connected diagnostic devices are fuelling the adoption of INAAT technology. Favourable regulatory guidelines and reimbursement policies are further propelling the market growth over the forecast period.
Segment Analysis
The global Isothermal Nucleic Acid Amplification Technology (Inaat) Market is segmented into assays, products, application, end-user, and region.
By assays, the market is segmented into loop-mediated isothermal amplification (LAMP), helicase-dependent amplification (HAD), nucleic acid sequence-based amplification (NASBA), and transcription-mediated amplification (TMA). The LAMP assay segment is expected to dominate the market as it offers advantages such as rapid amplification, high specificity, sensitivity, simple operation, and real-time detection.
Key Takeaways
The global isothermal nucleic acid amplification technology (INAAT) market is expected to witness high growth, exhibiting a CAGR of 8.4% over the forecast period, due to increasing prevalence of infectious diseases.
By region, North America is expected to dominate the global INAAT market during the forecast period. Factors such as advanced healthcare infrastructure, growing R&D funding, and growing awareness about innovative diagnosis drive the market growth in this region. The Asia Pacific region is anticipated to exhibit the fastest growth rate over the forecast period due to increasing disease burden, improving healthcare infrastructure, and growing focus on point-of-care testing.
Key players operating in the isothermal nucleic acid amplification technology (INAAT) market are Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN. Major players are focusing on new product launches, collaborations, and geographic expansions to increase their market share in the INAAT market.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it